Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunic Inc (NQ: IMUX ) 1.110 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 146,729 Open 1.120 Bid (Size) 1.080 (105) Ask (Size) 1.220 (2) Prev. Close 1.110 Today's Range 1.080 - 1.127 52wk Range 0.9451 - 3.110 Shares Outstanding 26,249,439 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying May 23, 2024 While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying. Via InvestorPlace Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day May 20, 2024 Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20. Via TheNewswire.com Performance YTD -23.45% -23.45% 1 Month -12.60% -12.60% 3 Month -15.91% -15.91% 6 Month -22.92% -22.92% 1 Year -27.92% -27.92% More News Read More Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day May 20, 2024 Via News Direct Immunic chief medical officer discusses promising treatments to mark World IBD Day May 17, 2024 Via News Direct Immunic chief medical officer discusses promising treatments to mark World IBD Day May 17, 2024 Via TheNewswire.com IMUX Stock Earnings: Immunic Misses EPS for Q1 2024 May 08, 2024 Via InvestorPlace Immunic's Earnings Outlook February 21, 2024 Via Benzinga Immunic: Q3 Earnings Insights November 14, 2023 Via Benzinga A Preview Of Immunic's Earnings November 13, 2023 Via Benzinga Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day May 16, 2024 Via News Direct Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day May 16, 2024 Via TheNewswire.com Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones May 09, 2024 Via News Direct Topics Intellectual Property Exposures Intellectual Property Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones May 09, 2024 Via TheNewswire.com Topics Intellectual Property Exposures Intellectual Property Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal May 01, 2024 Via News Direct Immunic "super excited" about latest PMS trial data October 11, 2023 Via News Direct Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal May 01, 2024 Via TheNewswire.com Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month March 21, 2024 Via News Direct Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month March 21, 2024 Via TheNewswire.com Immunic And 2 Other Stocks Under $2 Insiders Are Buying February 29, 2024 Via Benzinga Topics Stocks Exposures US Equities What's Going On With Immunic Stock? January 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 05, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 05, 2024 Via InvestorPlace Immunic CSO hails "great" progress with MS program October 24, 2023 Via News Direct Immunic CSO hails "great" progress with MS program October 24, 2023 Via TheNewswire.com Immunic "super excited" about latest PMS trial data October 11, 2023 Via TheNewswire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.